268 related articles for article (PubMed ID: 31408662)
1. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
Xue CD; Chen Y; Ren JL; Zhang LS; Liu X; Yu YR; Tang CS; Qi YF
Peptides; 2019 Nov; 121():170131. PubMed ID: 31408662
[TBL] [Abstract][Full Text] [Related]
2. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
[TBL] [Abstract][Full Text] [Related]
3. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of smooth muscle cell ILF3 alleviates intimal hyperplasia via HMGB1 mRNA degradation-mediated regulation of the STAT3/DUSP16 axis.
Hou YM; Xu BH; Zhang QT; Cheng J; Zhang X; Yang HR; Wang ZY; Wang P; Zhang MX
J Mol Cell Cardiol; 2024 May; 190():62-75. PubMed ID: 38583797
[TBL] [Abstract][Full Text] [Related]
5. SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
Qi W; Li Q; Liew CW; Rask-Madsen C; Lockhart SM; Rasmussen LM; Xia Y; Wang X; Khamaisi M; Croce K; King GL
Diabetologia; 2017 Mar; 60(3):585-596. PubMed ID: 27933336
[TBL] [Abstract][Full Text] [Related]
6. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO Mice.
Ni XQ; Lu WW; Zhang JS; Zhu Q; Ren JL; Yu YR; Liu XY; Wang XJ; Han M; Jing Q; Du J; Tang CS; Qi YF
Endocrine; 2018 Oct; 62(1):90-106. PubMed ID: 29943223
[TBL] [Abstract][Full Text] [Related]
8. The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.
de Jong RCM; Ewing MM; de Vries MR; Karper JC; Bastiaansen AJNM; Peters HAB; Baghana F; van den Elsen PJ; Gongora C; Jukema JW; Quax PHA
PLoS One; 2017; 12(10):e0185820. PubMed ID: 29016683
[TBL] [Abstract][Full Text] [Related]
9. Physalin B inhibits PDGF-BB-induced VSMC proliferation, migration and phenotypic transformation by activating the Nrf2 pathway.
Qiu L; Hu L; Liu X; Li W; Zhang X; Xia H; Zhang C
Food Funct; 2021 Nov; 12(21):10950-10966. PubMed ID: 34647944
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits intimal hyperplasia, vascular smooth muscle cell excessive proliferation, migration via blocking miR-21/PTEN/AKT/mTOR signaling pathway.
Huang R; Huang Y; Zeng G; Li M; Jin Y
Cell Cycle; 2020 Apr; 19(8):918-932. PubMed ID: 32202193
[TBL] [Abstract][Full Text] [Related]
11. A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.
Serrano RL; Yu W; Graham RM; Bryan RL; Terkeltaub R
PLoS One; 2019; 14(4):e0212235. PubMed ID: 30943188
[TBL] [Abstract][Full Text] [Related]
12. Role of polypyrimidine tract-binding protein 1/yin yang 2 signaling in regulating vascular smooth muscle cell proliferation and neointima hyperplasia.
Wang Z; Gan X; Qiu C; Yang D; Sun X; Zeng Z
Toxicol Appl Pharmacol; 2019 Nov; 383():114747. PubMed ID: 31499192
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of the effect and mechanism of vascular intimal hyperplasia in Tiam1 knockout mice.
Kou W; Xu X; Ji S; Chen M; Liu D; Wang K; Zhuang J; Yu Q; Zhao Q; Xu Y; Zhang H; Peng W
Biochem Biophys Res Commun; 2018 Feb; 497(1):248-255. PubMed ID: 29432743
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia.
Fukai N; Kenagy RD; Chen L; Gao L; Daum G; Clowes AW
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1356-62. PubMed ID: 19592464
[TBL] [Abstract][Full Text] [Related]
15. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
16. Connexin37 reduces smooth muscle cell proliferation and intimal hyperplasia in a mouse model of carotid artery ligation.
Allagnat F; Dubuis C; Lambelet M; Le Gal L; Alonso F; Corpataux JM; Déglise S; Haefliger JA
Cardiovasc Res; 2017 Jun; 113(7):805-816. PubMed ID: 28449099
[TBL] [Abstract][Full Text] [Related]
17. MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62/mTORC1-mediated glucose metabolism.
Sun X; Yang Y; Zhao W; Wang M; Chen Y; Wang J; Yang D; Yang Y
Atherosclerosis; 2024 Mar; 390():117470. PubMed ID: 38342025
[TBL] [Abstract][Full Text] [Related]
18. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
19. Inhibition of PIKfyve Ameliorates the Proliferation and Migration of Vascular Smooth Muscle Cells and Vascular Intima Hyperplasia By Reducing mTORC1 Activity.
Gu M; Wang Z; Feng F; Yang Y; Sun X; Yang D
J Cardiovasc Pharmacol; 2022 May; 79(5):739-748. PubMed ID: 35275098
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid B inhibits Ang II-induced VSMC proliferation in vitro and intimal hyperplasia in vivo by downregulating miR-146a expression.
Zhao XS; Zheng B; Wen Y; Sun Y; Wen JK; Zhang XH
Phytomedicine; 2019 May; 58():152754. PubMed ID: 31009837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
